Compare CLPS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | CCM |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 23.8M |
| IPO Year | 2018 | 2009 |
| Metric | CLPS | CCM |
|---|---|---|
| Price | $0.85 | $4.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.4K | 3.2K |
| Earning Date | 10-17-2025 | 09-26-2025 |
| Dividend Yield | ★ 15.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $164,481,414.00 | $51,056,841.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.17 | N/A |
| 52 Week Low | $0.82 | $3.54 |
| 52 Week High | $1.88 | $10.77 |
| Indicator | CLPS | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 47.23 |
| Support Level | $0.84 | $4.12 |
| Resistance Level | $0.90 | $4.99 |
| Average True Range (ATR) | 0.03 | 0.26 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 4.44 | 48.96 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.